
Melody Noel Brown
Examiner (ID: 8663, Phone: (571)272-2599 , Office: P/2917 )
| Most Active Art Unit | 2917 |
| Art Unit(s) | 2915, 2901, 2917, 2911 |
| Total Applications | 11867 |
| Issued Applications | 11761 |
| Pending Applications | 2 |
| Abandoned Applications | 102 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18589202
[patent_doc_number] => 11738074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Vaccines against malaria transmission
[patent_app_type] => utility
[patent_app_number] => 17/826617
[patent_app_country] => US
[patent_app_date] => 2022-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 24
[patent_no_of_words] => 14178
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826617
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/826617 | Vaccines against malaria transmission | May 26, 2022 | Issued |
Array
(
[id] => 18978851
[patent_doc_number] => 11904005
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Compositions and methods of enhancing immune responses to
[patent_app_type] => utility
[patent_app_number] => 17/824378
[patent_app_country] => US
[patent_app_date] => 2022-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9866
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17824378
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/824378 | Compositions and methods of enhancing immune responses to | May 24, 2022 | Issued |
Array
(
[id] => 17991286
[patent_doc_number] => 20220357323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => METHOD AND A SOLID SUPPORT FOR DETECTING TICK-BORNE MICROBES IN A BIOLOGICAL SAMPLE
[patent_app_type] => utility
[patent_app_number] => 17/752277
[patent_app_country] => US
[patent_app_date] => 2022-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17752277
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/752277 | Method and a solid support for detecting tick-borne microbes in a biological sample | May 23, 2022 | Issued |
Array
(
[id] => 17828485
[patent_doc_number] => 20220265789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => ANTIGENS FOR DETECTING TOXOPLASMA INFECTION BY MONITORING CELLULAR IMMUNITY
[patent_app_type] => utility
[patent_app_number] => 17/742023
[patent_app_country] => US
[patent_app_date] => 2022-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9273
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17742023
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/742023 | ANTIGENS FOR DETECTING TOXOPLASMA INFECTION BY MONITORING CELLULAR IMMUNITY | May 10, 2022 | Abandoned |
Array
(
[id] => 20207506
[patent_doc_number] => 20250277226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-04
[patent_title] => IMPROVED BIOTECHNOLOGICAL METHOD FOR PRODUCING GUANIDINO ACETIC ACID (GAA) BY INACTIVATION OF AN AMINO ACID EXPORTER
[patent_app_type] => utility
[patent_app_number] => 18/562157
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18562157
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/562157 | IMPROVED BIOTECHNOLOGICAL METHOD FOR PRODUCING GUANIDINO ACETIC ACID (GAA) BY INACTIVATION OF AN AMINO ACID EXPORTER | May 9, 2022 | Pending |
Array
(
[id] => 17792125
[patent_doc_number] => 20220251216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => ANTI HLA-G SPECIFIC ANTIBODIES
[patent_app_type] => utility
[patent_app_number] => 17/728483
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728483
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/728483 | Anti HLA-G specific antibodies | Apr 24, 2022 | Issued |
Array
(
[id] => 19170963
[patent_doc_number] => 20240156937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => BACERIOPHAGE VIRUS-LIKE PARTICLES VACCINES FOR CHLAMYDIA TRACHOMATIS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/278118
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26693
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18278118
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/278118 | BACERIOPHAGE VIRUS-LIKE PARTICLES VACCINES FOR CHLAMYDIA TRACHOMATIS INFECTIONS | Apr 19, 2022 | Pending |
Array
(
[id] => 17774200
[patent_doc_number] => 20220240549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => ACETIC ACID BACTERIA-CONTAINING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/723123
[patent_app_country] => US
[patent_app_date] => 2022-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24859
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17723123
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/723123 | Acetic acid bacteria-containing composition | Apr 17, 2022 | Issued |
Array
(
[id] => 18666279
[patent_doc_number] => 11773157
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Compositions and methods for treating and preventing
[patent_app_type] => utility
[patent_app_number] => 17/659466
[patent_app_country] => US
[patent_app_date] => 2022-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 13
[patent_no_of_words] => 11268
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17659466
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/659466 | Compositions and methods for treating and preventing | Apr 14, 2022 | Issued |
Array
(
[id] => 19353062
[patent_doc_number] => 12053487
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => Mitigation of cryptosporidiosis using hydrogen peroxide-generating compositions
[patent_app_type] => utility
[patent_app_number] => 17/719674
[patent_app_country] => US
[patent_app_date] => 2022-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7446
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17719674
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/719674 | Mitigation of cryptosporidiosis using hydrogen peroxide-generating compositions | Apr 12, 2022 | Issued |
Array
(
[id] => 19345472
[patent_doc_number] => 20240254435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => VARIANT BACTERIAL STRAINS AND PROCESSES FOR PROTEIN OR BIOMASS PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/553946
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18553946
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/553946 | VARIANT BACTERIAL STRAINS AND PROCESSES FOR PROTEIN OR BIOMASS PRODUCTION | Apr 6, 2022 | Pending |
Array
(
[id] => 17988869
[patent_doc_number] => 20220354906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => Probiotic Immunomodulatory Compositions
[patent_app_type] => utility
[patent_app_number] => 17/714205
[patent_app_country] => US
[patent_app_date] => 2022-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23483
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714205
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/714205 | Probiotic immunomodulatory compositions | Apr 5, 2022 | Issued |
Array
(
[id] => 19246869
[patent_doc_number] => 20240197853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => MULTIVALENT CHOLERA MULTIEPITOPE FUSION ANTIGEN (MEFA) AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/554423
[patent_app_country] => US
[patent_app_date] => 2022-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18554423
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/554423 | MULTIVALENT CHOLERA MULTIEPITOPE FUSION ANTIGEN (MEFA) AND METHODS OF USE | Apr 4, 2022 | Pending |
Array
(
[id] => 19170961
[patent_doc_number] => 20240156935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => Vaccine Compositions for Trypanosomatids
[patent_app_type] => utility
[patent_app_number] => 18/552827
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552827
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552827 | Vaccine Compositions for Trypanosomatids | Mar 30, 2022 | Pending |
Array
(
[id] => 19201495
[patent_doc_number] => 20240173394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => IMMUNOGENIC FUSION PROTEIN
[patent_app_type] => utility
[patent_app_number] => 18/284513
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12825
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18284513
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/284513 | IMMUNOGENIC FUSION PROTEIN | Mar 28, 2022 | Pending |
Array
(
[id] => 18664885
[patent_doc_number] => 11771750
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Composition and method for generating immunity to
[patent_app_type] => utility
[patent_app_number] => 17/705461
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 20
[patent_no_of_words] => 10812
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705461
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/705461 | Composition and method for generating immunity to | Mar 27, 2022 | Issued |
Array
(
[id] => 18020617
[patent_doc_number] => 20220372116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => OPTIMIZED CROSSLINKERS FOR TRAPPING A TARGET ON A SUBSTRATE
[patent_app_type] => utility
[patent_app_number] => 17/698645
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17698645
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/698645 | Optimized crosslinkers for trapping a target on a substrate | Mar 17, 2022 | Issued |
Array
(
[id] => 20678145
[patent_doc_number] => 20260116957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-04-30
[patent_title] => PHARMACEUTICAL COMPOSITION FOR AMELIORATING ACUTE LUNG INJURY AND ACUTE WORSENING OF PULMONARY FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 18/282975
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24220
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282975
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/282975 | PHARMACEUTICAL COMPOSITION FOR AMELIORATING ACUTE LUNG INJURY AND ACUTE WORSENING OF PULMONARY FIBROSIS | Mar 17, 2022 | Pending |
Array
(
[id] => 18517645
[patent_doc_number] => 11707515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Modified
[patent_app_type] => utility
[patent_app_number] => 17/687313
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 12
[patent_no_of_words] => 12942
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687313
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687313 | Modified | Mar 3, 2022 | Issued |
Array
(
[id] => 18604703
[patent_doc_number] => 11746153
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Binding molecules specific for FcgRIIA and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/684018
[patent_app_country] => US
[patent_app_date] => 2022-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 47
[patent_no_of_words] => 24416
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17684018
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/684018 | Binding molecules specific for FcgRIIA and uses thereof | Feb 28, 2022 | Issued |